BBCR offers expertise in the areas of Product Development Planning and Validation or Qualification when biomarkers are a part of your product development plan.

clinical trials tag icon Tags: | | | |
– Boston Biotech Clinical Research (BBCR). Strategic Clinical Innovation Experts. Rare Disease, Clinical Trials, Clinical Research, & Biologics. We work with biotech, pharmaceutical, and device companies to develop clinical/regulatory road-maps consisting with simplified clinical programs, streamlined protocols, and cost-effective clinical trials. Our experienced team provides innovative strategies that meet your goals.

by | Oct 26, 2021 | Medical Affairs and Clinical Research, Rare Disease, Real World Evidence

BBCR offers expertise in the areas of Product Development Planning and Validation or Qualification when biomarkers are a part of your product development plan.

How BBCR Can Help

BBCR’s biomarker expert is renowned in the field. He is a senior advisor on the biomarker committee at the NIH and former global biomarker expert at Novartis, Roche, and Pfizer.

Plan

Insightful strategy is the most effective way to ensure quality when including biomarkers into your product development plan.

READ MORE

Validation or Qualification

Understanding where to go if biomarker validation takes your study in a different direction can create valuable efficiencies in bringing a product to market.

READ MORE

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

Pin It on Pinterest